Although the biological significance underlying NG2 proteoglycan involvement in cancer progression needs to be better defined, the expression of NG2 is closely associated with the poor prognoses in hepatocellular carcinoma, pancreatic malignancy and anaplastic thyroid cancer [27–29]. This evidence concerns the gene CSPG4 and cancer.